Testosterone Enanthate is a long-acting esterified testosterone virtually interchangeable with Testosterone Cypionate. It is the most widely used testosterone ester globally and serves as the standard base compound for anabolic steroid cycles, providing reliable anabolic and androgenic effects.
Notes
Testosterone Enanthate and Cypionate are nearly identical in practice. The enanthate ester has a slightly shorter half-life by approximately 1 day, but this difference is clinically negligible. Many users and clinicians use them interchangeably. The same AI and hCG protocols apply as with Cypionate.
Testosterone Enanthate functions identically to endogenous testosterone once the enanthate ester is cleaved by blood esterases. It binds to intracellular androgen receptors, translocates to the nucleus, and modulates gene transcription to increase protein synthesis, nitrogen retention, and satellite cell activation in skeletal muscle. It also undergoes 5-alpha reduction to DHT (responsible for androgenic effects in skin, prostate, and hair follicles) and aromatization to estradiol (necessary for bone health, lipid metabolism, and libido at physiological levels, but problematic in excess). Testosterone also stimulates erythropoietin production in the kidneys, enhancing red blood cell production.
After intramuscular injection, Testosterone Enanthate forms an oil depot that releases testosterone as the ester is hydrolyzed. Peak plasma levels occur within 24-48 hours, followed by a gradual decline with a terminal half-life of 7-10 days. The slightly shorter ester chain compared to cypionate results in marginally faster release kinetics, though in practice the two are interchangeable. Metabolism occurs primarily hepatically through oxidative pathways and glucuronide/sulfate conjugation. Steady-state is reached after approximately 4-5 weeks of consistent dosing. Urinary excretion of metabolites can be detected for 3-4 months after cessation.
Typical Dose
150-200mg/week (TRT), 300-500mg/week (beginner cycle), 500-750mg/week (intermediate), 750-1000mg/week (advanced)
Frequency
2x per week (e.g., Monday/Thursday) for stable blood levels; once weekly acceptable for TRT
Administration
Intramuscular injection (gluteal, deltoid, or vastus lateralis)
Half-Life
7-10 days
Contraindications
Wait 14 days after last Testosterone Enanthate injection to begin PCT. Standard protocol: Nolvadex (tamoxifen) 20mg/day for 6 weeks, or Clomid 50mg/day for 4 weeks followed by 25mg/day for 2 weeks. If hCG was run during cycle, discontinue it 3-4 days before starting SERMs. Confirm hormonal recovery with bloodwork (LH, FSH, Total Testosterone) 4-6 weeks after PCT completion.